Fineline Cube

Follow:
14778 Articles
Ascletis Pharma's ASC40 Earns FDA Breakthrough Therapy Designation for Fibrotic MASH
CompanyDrug

Ascletis Pharma’s ASC40 Earns FDA Breakthrough Therapy Designation for Fibrotic MASH

HitGen Inc. Partners with Ablink Biotech to Develop Antibody-Oligonucleotide Conjugates
CompanyDeals

HitGen Inc. Partners with Ablink Biotech to Develop Antibody-Oligonucleotide Conjugates

Sichuan Biokin's BL-B01D1 Earns Breakthrough Therapy Designation for Esophageal Cancer from China's CDE
CompanyDrug

Sichuan Biokin’s BL-B01D1 Earns Breakthrough Therapy Designation for Esophageal Cancer from China’s CDE

Merck's Keytruda Meets Primary Endpoint in Phase III Study for Head and Neck Cancer
CompanyDrug

Merck’s Keytruda Meets Primary Endpoint in Phase III Study for Head and Neck Cancer

Boehringer Ingelheim's Survodutide Earns FDA Breakthrough Therapy Designation for MASH Treatment
CompanyDrug

Boehringer Ingelheim’s Survodutide Earns FDA Breakthrough Therapy Designation for MASH Treatment

Eli Lilly Appoints Thomas J. Fuchs as First Chief AI Officer to Lead AI Initiatives
Company

Eli Lilly Appoints Thomas J. Fuchs as First Chief AI Officer to Lead AI Initiatives

Zephyrm Bioscience Limited Files for IPO on Hong Kong Stock Exchange
CompanyDeals

Zephyrm Bioscience Limited Files for IPO on Hong Kong Stock Exchange

Pfizer Halts Development of Sisunatovir, an RSV Antiviral, After Phase II/III Trials
CompanyDrug

Pfizer Halts Development of Sisunatovir, an RSV Antiviral, After Phase II/III Trials

Biogen's China Unit Gets Conditional NMPA Nod for Qalsody (Tofersen) in ALS Treatment
CompanyDrug

Biogen’s China Unit Gets Conditional NMPA Nod for Qalsody (Tofersen) in ALS Treatment

Joincare Pharmaceutical Secures NMPA Approval for Triptorelin Microspheres to Treat Endometriosis
CompanyDrug

Joincare Pharmaceutical Secures NMPA Approval for Triptorelin Microspheres to Treat Endometriosis

CSPC Pharmaceutical Secures NMPA Approval for Omalizumab Biosimilar
CompanyDrug

CSPC Pharmaceutical Secures NMPA Approval for Omalizumab Biosimilar

Ningbo Menovo Pharmaceutical Partners with Nanjing Huawe Medicine for High-End Product Development
CompanyDeals

Ningbo Menovo Pharmaceutical Partners with Nanjing Huawe Medicine for High-End Product Development